Skip to main content
. 2023 May 15;17(4):782–789. doi: 10.31616/asj.2022.0209

Table 2.

Characteristics of the included studies

Author (year) No. of patients Age (yr) Sex (male/female)


PRP Control PRP Control
Won et al. [24] (2022) 30 51±18.1 50.5±17 6/8 6/10

Ruiz-Lopez et al. [25] (2020) 50 68±13.06 61±12.6 11/14 10/15

Tuakli-Wosornu et al. [26] (2016) 58 41.4±8.08 43.8±8.91 14/15 3/16

Values are presented as mean±standard deviation or number of patients.

PRP, platelet-rich plasma.